Biotechnology · Irvine, CA · Founded 2024 · Privately Held (backing)
Operator of a therapeutics company intended to address Complex Regional Pain Syndrome Type 1 (CRPS-1). Ambros Therapeutics is based in Irvine, CA and was founded in 2024. It was valued at $250 million at its early-stage round in Dec 2025, the last priced event on record. It has raised $154 million across 1 recorded round; the latest was a $154 million Series A in Dec 2025.
PMV mark · valuation
$250.0M
Oct 2026
Priced at
its early-stage round
Dec 2025
Total raised
$154.0M
Last round
Early Stage VC (Series A)
Dec 2025
Cap table — not yet on record
Ambros Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ambros Therapeutics with a free account
·Watch Ambros Therapeutics: the Monday email on marks, rounds and moves
Where does Ambros Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Ambros Therapeutics's 1 recorded funding rounds.
